POLYMORPHIC ABILITY TO METABOLIZE PROPRANOLOL ALTERS 4-HYDROXYPROPRANOLOL LEVELS BUT NOT BETA-BLOCKADE

被引:86
作者
RAGHURAM, TC
KOSHAKJI, RP
WILKINSON, GR
WOOD, AJJ
机构
[1] VANDERBILT UNIV,MED CTR,SCH MED,DEPT PHARMACOL,NASHVILLE,TN 37232
[2] VANDERBILT UNIV,MED CTR,SCH MED,DEPT MED,NASHVILLE,TN 37232
关键词
D O I
10.1038/clpt.1984.138
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:51 / 56
页数:6
相关论文
共 45 条
[1]  
ASLANIAN W, 1983, PHARMACOLOGIST, V25, P218
[2]   PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE [J].
BERTILSSON, L ;
DENGLER, HJ ;
EICHELBAUM, M ;
SCHULZ, HU .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) :153-155
[3]   NORTRIPTYLINE AND ANTIPYRINE CLEARANCE IN RELATION TO DEBRISOQUINE HYDROXYLATION IN MAN [J].
BERTILSSON, L ;
EICHELBAUM, M ;
MELLSTROM, B ;
SAWE, J ;
SCHULZ, HU ;
SJOQVIST, F .
LIFE SCIENCES, 1980, 27 (18) :1673-1677
[4]  
BRUCE R A, 1969, Progress in Cardiovascular Diseases, V11, P371, DOI 10.1016/0033-0620(69)90027-9
[5]  
CLEAVELAND CR, 1972, CLIN PHARMACOL THER, V13, P181
[6]   PLASMA PROPRANOLOL LEVELS IN QUANTITATIVE ASSESSMENT OF BETA-ADRENERGIC BLOCKADE IN MAN [J].
COLTART, DJ ;
SHAND, DG .
BRITISH MEDICAL JOURNAL, 1970, 3 (5725) :731-&
[7]   INFLUENCE OF THE GENETICALLY CONTROLLED DEFICIENCY IN DEBRISOQUINE HYDROXYLATION ON ANTIPYRINE METABOLITE FORMATION [J].
DANHOF, M ;
IDLE, JR ;
TEUNISSEN, MWE ;
SLOAN, TP ;
BREIMER, DD ;
SMITH, RL .
PHARMACOLOGY, 1981, 22 (06) :349-358
[8]   ANTIPYRINE METABOLISM IN RELATION TO POLYMORPHIC OXIDATIONS OF SPARTEINE AND DEBRISOQUINE [J].
EICHELBAUM, M ;
BERTILSSON, L ;
SAWE, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (03) :317-321
[9]   DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].
EICHELBAUM, M ;
SPANNBRUCKER, N ;
STEINCKE, B ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187
[10]  
EICHELBAUM M, 1977, CLIN PHARMACOKINET, V7, P1